Unknown

Dataset Information

Advances in the management of pediatric genitourinary rhabdomyosarcoma.


ABSTRACT: Recent clinical trials have revealed several unanticipated complexities in the optimal management of genitourinary rhabdomyosarcoma (RMS). Improvement in outcomes for low- and intermediate-risk RMS over the past several decades led to the design of clinical trials aimed at reducing acute and late toxicity from extirpative surgeries, conventional radiotherapy, and cytotoxic chemotherapy. Results from these studies are mixed and have illuminated areas where historical risk stratification strategies need refining. Although radiotherapy has now become the standard for local control for most patients with genitourinary RMS, recent studies are demonstrating that there may be opportunities to minimize radiation toxicity while maintaining acceptable failure-free survival. A reduction in cyclophosp

SUBMITTER: Deel MD 

PROVIDER: S-EPMC7658124 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature